Cost-effectiveness analysis of a screening program for gallbladder disease in Chile;Análisis de costo-efectividad de un programa preventivo de enfermedad vesicular en Chile

Revista Medica de Chile

Volumn 130, Issue 4, 2002, Pages 447-459

  Puschel I, Klaus ^a,c,e   Sullivan, Sean ^b   Montero L, Joaquín ^a   Thompson, Beti ^c   Díaz F, Alfonso ^d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^e NONE   (Chile)

Author keywords

Cholecystectomy; Cholelithiasis; Gallbladder diseases

Indexed keywords

ADULT; ARTICLE; CHILE; CHOLECYSTECTOMY; CHOLELITHIASIS; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECHOGRAPHY; FEMALE; GALLBLADDER DISEASE; HUMAN; MASS SCREENING; METHODOLOGY; RISK FACTOR;

ADULT; CHILE; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLELITHIASIS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; GALLBLADDER DISEASES; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 0347308014     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. NATIONAL INSTITUTE OF HEALTH. Consensus development conference statement on gallstones and laparoscopic cholecystectomy. Am J Surg 1993; 165: 390-6.
2. FRIEDMAN G. Natural history of asymptomatic and symptomatic gallstones. Am J Surgery 1993; 165: 399-409.
3. RANSOHOFF D, GRACIE WA. Treatment of gallstones. Ann Intern Med 1993; 119: 606-22.
4. COVARRUBIAS C, VALDIVIESO V, NERVI F. Epidemiology of gallstone disease in Chile. Capocaccia L, Ricci G, Angelico F, eds. Epidemiology and prevention of gallstone disease. Lancaster, England: MTP 1984; 26-30.
5. NERVI F, DUARTE I, GÓMEZ G, RODRÍGUEZ G, DEL PINO G, FERREIRO O ET AL. Frequency of Gallbladder cancer in Chile, a high risk area. Int J Cancer 1988; 41: 657-60.
6. DIEHL A. Gallstone disease in Mestizo Hispanics. Gastroenterology 1998; 115: 1012-14.
7. COVARRUBIAS C, DEL PINO G, FERREIRO O, NERVI F. Epidemiología e historia natural de la litiasis biliar. Implicancias para el manejo clínico de la enfermedad. Reu Méd Chile 1992; 120: 432-8.
8. CSENDES A, CSENDES P, BURDILES P. Seguimiento a largo plazo de pacientes con colelitiasis asintomática y sintomática no operados. Rev Méd Chile 1996; 124; 1219-24.
9. LA VECCHIA C, LEVI F, LUCCHINI F, FRANCESCHI S. Trends in mortality from nonneoplastic gallbladder disease. Ann Epidemiol 1995; 5: 215-20.
10. nd ed. Oxford University Press, 1996: 794-805.
11. SERRA I, CALVO A, MATURANA M, SHARP A. Biliary-tract cancer in Chile. Int J Cancer 1990; 46: 965-71.
12. FERRECCIO C, CHIANALE J, GONZÁLEZ C, NERVI F. Epidemiología descriptiva del cáncer digestivo en Chile (1982-1991): una aproximación desde la mortalidad. Alfabeta Impresores, Santiago, Chile. 1995.
13. CUBERTAFOND P, GAINANT A, CUCCHIARO G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg 1994; 219: 275-80.
14. DONOHUE J, STEWART A, MENCK H. The National Cancer Data Base. Report on carcinoma of the gallbladder, 1989-1995. Cancer 1998; 83: 2618-28.
15. ZATONSKI W, LA VECCHIA C, PRZEWOZNIAK K, MAISONNEUVE P, LOWENFELS AB. Risk factors for gallbladder cancer: A Polish case-control study. Int J Cancer 1992; 51: 707-11.
16. MIQUEL JF, COVARRUBIAS C, VILLARROEL L, GELTRUDE M, GRECO A, PUGLIELLI L ET AL. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115: 937-46.
17. RANSOHOFF DF, GRACIE W, WOLFENSON L, NEUHAUSER D. Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med 1983; 99: 199-204.
18. KOTTKE T, FELDMAN R, ALBERT D. The risk ratio is insufficient for clinical decisions. The case of prophylactic cholecystectomy. Med Decis Making 1984; 4: 177-94.
19. SCHWESINGER WH, DIEHL AK. Changing indications for laparoscopic cholecystectomy. Surg Clin North Am 1996; 76: 493-504.
20. Pontificia Universidad Católica de Chile. Codigo de Prestaciones Institucionales y Fonasa Nivel III, Octubre 1998.
21. APABLAZA S. Colecistectomía laparoscópica. Rev Chil Cir 1997; 49: 194-205.
22. GLASINOVIC JC, GONZALEZ C, MEGE RM, MARINOVICH I, VALDIVIA MT, ALVARADO A. Enfermedad biliar litiásica sintomática. Comparación entre nombres y mujeres sometidos a colecistectomía. Rev Méd Chile 1991; 119: 1361-6.
23. IBÁÑEZ L. Colecistectomía laparoscópica. Bol Esc Med P Univ Cat de Chile 1994; 23: 103-8.
24. Mc SHERRY CK, FERSTENDERG H, CALHOUN WF. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985; 202: 59-63.
25. SAMA C, MORSELL-LABATE AM, VENTUROLI N. The natural history of asymptomatic and symptomatic gallstones: 10 years of follow-up in the Simrione study. Hepatology 1992; 16: 87.
26. FRIEDMAN GD, RAVIOLA CA, FIREMAN B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989; 42: 127-36.
27. ATTILI AF, CAPRI R, REPICE AM, MASSELLI S. The natural history of gallstones: the GREPCO experience. Hepatology 1995; 21: 656-60.
28. THISTLE JL, CLEARY PA, LACHIN JM, TYOR MP, HERSH T. The natural history of cholelitiasis: The National Cooperative Gallstone Study. Ann Intern Med 1984; 110: 171-5.
29. SERRA I, CALVO A, MATURANA M, MEDINA E, SHARP A. Changing trends of gallbladder cancer in Chile, a high risk area. Int J Cancer 1990; 45: 376-7.
30. CSENDES A, KORN O, MEDINA E, BECERRA M, CSENDES P. Mortalidad de la cirugia biliar en Chile en 1990. Estudio cooperativo de 17 hospitales. Rev Méd Chile 1993; 121: 937-42.
31. SHEA J, HEALEY MJ, BERLIN JA, CLARKE JR, MALET PF, STAROSCIK R, SHWARTZ J, WILLIAMS S. Mortality and complications associated with laparoscopic surgery: A meta-analysis. Ann Surg 1996; 224: 609-20.
32. BASS EB, PITT HA, LILLEMOE KD. Cost-Effectiveness of laparoscopic cholecystectomy versus open cholecystectomy. Am J Surg 1993; 165: 466-71.
33. GARBER SM, KORMAN J, COSGROVE JR, COHEN JR. Early laparoscopic cholecystectomy for acute cholcystitis. Surg Endosc 1997; 11: 347-50.
34. LOWENFELS AB, WALKER AM, ALTHAUS DP, ALTHAUS DP, TOWNSEND G, DOMELLOF L. Gallstone growth, size and risk of gallbladder cancer: an interracial study. Int J Epidemiol 1989; 18: 50-4.
35. ROA I, ARAYA JC, VILLASECA M, ARETXABALA X, RIEDEMAN P, ENDOH K ET AL. Preneoplasic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology 1996; 111: 232-6.
36. DIEHL AK. Gallstone size and the risk of gallbladder cancer. JAMA 1983; 250: 2323-6.
37. VITETTA L, SALI A, LITTLE P, MIRAZEK L. Gallstones and gallbladder carcinoma. Aust N Z J Surg 2000; 70: 667-73.
38. CSENDES A, BECERRA M, ROJAS J, MEDINA E. Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: a prospective study of 592 cases. J Gastrointest Surg 2000; 4: 481-5.
39. ZATONSKY WA, LOWENFELS AB, BOYLE P, MAISONEUVE P, BUENO DE. MESQUITA HD, MOERMAN CJ ET AL. Epidemiologic aspects of gallbladder cancer: A Case-Control study of the SEARCH program of the international agency for researchi on cancer. J Natl Cancer lnst 1997; 89; 1132-7.
40. SHEA J, BERLIN J, ESCARCE J, CLARKE J, KINOSIAN B, CABANA M ET AL. Revisited estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Mod 1994; 154: 2573-81.
41. BRET PM, CORDOVEZ R, ATRI M, ILLESCAS FF, ALDIS A, HERSHON S. Accuracy of ultrasound in counting and measuring gallstones. Gastrointest Radiol 1991; 16: 315-9.
42. rd edition. Oxford medical publications 1997; 1583-600.
43. COVARRUBIAS C, MERINO G, CRUZ F, DEL Rio P, DUARTE I, MORALES B, VALDIVIESO V. Correlación entre la ecotomografía y la anatomía patológica de la vesí cula biliar. Rev Méd Chile 1992; 120: 1227-30.
44. EDDY DM. Screening for Breast Cancer. Ann Intern Med 1989; 111: 389-99
45. EDDY DM. Screening for colorectal cancer. Ann Intern Med 1990; 113: 373-84.
46. Banco Mundial, Oficina Regional para América Latina y el Caribe. Chile, el desafío de las políticas de salud del adulto. 1995.
47. NAIMARK D, DETSKY A. The meaning of life expectancy: What is a clinically significant gain? Med Dec Making 1992; 12: 344.
48. ARETXABALA X, ROA I, BURGOS L. Gallbladder cancer in Chile. A report of 54 potentially resemble tumors. Cancer 1992; 69; 60-5.
49. Instituto Nacional de Estadísticas. Mnjcrcs de Chile. Radiografia en Números. Marzo 1998.